Efficacy and safety of intravenous beta-blockers in acute atrial fibrillation and flutter is dependent on beta-1 selectivity: a systematic review and meta-analysis of randomised trials.
Madeleine PerrettNisha GohilOtilia TicaKarina V BuntingDipak KotechaPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
Across all intravenous beta-blockers, there was no difference with other medications for acute heart rate control in atrial fibrillation and flutter. Efficacy and safety may be improved by choosing beta-blockers with higher beta-1 selectivity.
Keyphrases
- atrial fibrillation
- heart rate
- catheter ablation
- liver failure
- angiotensin converting enzyme
- heart rate variability
- heart failure
- oral anticoagulants
- left atrial
- clinical trial
- blood pressure
- high dose
- left atrial appendage
- drug induced
- direct oral anticoagulants
- open label
- venous thromboembolism
- intensive care unit
- study protocol
- mitral valve